Published in Cancer Weekly, June 26th, 1995
The patent is assigned to Yale University by the inventor Peter M. Glazer, M.D., Ph.D., Assistant Professor of Therapeutic Radiology at Yale University School of Medicine.
The patent application covers methods of repairing mutations in living cells, using triple-strand oligonucleotides linked to DNA-interacting drugs, such as alkylators, intercalators or strand-breakers. This patent has an effective filing date of June 25, 1993, and is considered to be fundamental to the development of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.